Allogene Therapeutics Inc...
(ALLO)
undefined
undefined%
At close: undefined
1.94
2.92%
After-hours Dec 13, 2024, 06:59 PM EST
Ratios (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| PE Ratio | -0.38 | -0.68 | -2.07 | -3.25 | -3.56 | -0.92 | -368521.38 |
| PS Ratio | 1325.66 | 926.33 | 13.16 | 0.00 | 0.00 | 0.00 | 0.00 |
| PB Ratio | 0.25 | 0.34 | 0.55 | 0.70 | 1.04 | 0.28 | -368521.38 |
| P/FCF Ratio | -0.53 | -1.00 | -2.46 | -4.20 | -3.49 | -4.07 | 0.00 |
| P/OCF Ratio | -0.53 | -1.02 | -2.74 | -6.60 | -4.78 | -4.36 | 0.00 |
| OCF/S Ratio | -625.61 | -226.87 | -1.20 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quick Ratio | 3.10 | 2.71 | 4.30 | 2.79 | 4.57 | 6.19 | 0.00 |
| Current Ratio | 3.10 | 2.42 | 4.20 | 2.24 | 4.12 | 3.97 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -14.36 | 0.00 |
| Return on Equity (ROE) | -63.89% | -49.53% | -26.72% | -21.63% | -29.35% | -30.08% | 100.00% |
| Return on Assets (ROA) | -50.91% | -40.37% | -23.57% | -19.01% | -25.72% | -27.33% | 0.00% |
| Return on Capital (ROIC) | -54.10% | -43.99% | -25.83% | -22.78% | -29.50% | -25.91% | 100.00% |
| Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Gross Profit Margin | -63899.74% | -1695.99% | 16.51% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | -86122.37% | -33931.58% | -159.03% | 0.00% | 0.00% | 0.00% | 0.00% |